Back to today’s briefing

Story perspectives

Over 1 Million UK Users Face GLP-1 Drug Risks

6/26/2025

37 6

Summary

Story summary

In the UK, more than a million users of GLP-1 drugs such as Mounjaro, Wegovy, and Ozempic are facing alarming side effects, including acute pancreatitis and even fatalities. The MHRA is delving into possible genetic factors behind these adverse reactions. While these medications pose risks, they also provide crucial support for managing diabetes and obesity.

1 of 1

Story summary

In the UK, more than a million users of GLP-1 drugs such as Mounjaro, Wegovy, and Ozempic are facing alarming side effects, including acute pancreatitis and even fatalities. The MHRA is delving into possible genetic factors behind these adverse reactions. While these medications pose risks, they also provide crucial support for managing diabetes and obesity.